Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction | Zendy

Bindu Kalesan | Zendy; Thomas Pilgrim | Zendy; Katja Heinimann | Zendy; Lorenz Räber | Zendy; Giulio Stefanini | Zendy; Marco Valgimigli | Zendy; Bruno R. da Costa | Zendy; François Mach | Zendy; Thomas F. Lüscher | Zendy; Bernhard Meier | Zendy; Stephan Windecker | Zendy; Peter Jüni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction

Author(s) -

Bindu Kalesan,

Thomas Pilgrim,

Katja Heinimann,

Lorenz Räber,

Giulio Stefanini,

Marco Valgimigli,

Bruno R. da Costa,

François Mach,

Thomas F. Lüscher,

Bernhard Meier,

Stephan Windecker,

Peter Jüni

Publication year - 2012

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehs036

Subject(s) - medicine , bare metal , cardiology , myocardial infarction , st segment , drug , drug eluting stent , coronary restenosis , percutaneous coronary intervention , stent , restenosis , pharmacology

To evaluate safety and effectiveness of early generation drug-eluting stents (DES) compared with bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), and to determine whether benefits and risks vary over time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research